@article{39074e5c24f543b8b5b596c39a54535a,
title = "Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes",
abstract = "Cardiovascular disease (CVD) is the most common cause of morbidity and mortality for patients with diabetes mellitus (DM). Although the burden of atherosclerotic CVD (ASCVD) is well documented, heart failure (HF) has been an under-appreciated CVD complication of DM. However, as more patients with DM live longer and survive acute ASCVD events, the distribution of CVD complications has evolved. This review summarizes the epidemiology of DM, the relative risk and prognosis of both ASCVD and HF following a diagnosis of DM, and the likelihood of cause-specific CVD mortality in patients with DM.",
keywords = "Atherosclerotic cardiovascular disease, Diabetes, Heart failure, Risk",
author = "Nelson, {Adam J.} and Peterson, {Eric D.} and Pagidipati, {Neha J.}",
note = "Funding Information: AJN is supported by the National Heart Foundation of Australia and the Royal Australian College of Physicians . EDP has received research and consulting support from Amgen, Sanofi, AstraZeneca, Merck, Amarin, and Janssen. NJP has received research support to the institution from Amarin, Novo Nordisk, Boehringer Ingelheim, Regeneron, and AstraZeneca. Funding Information: AJN is supported by the National Heart Foundation of Australia and the Royal Australian College of Physicians. EDP has received research and consulting support from Amgen, Sanofi, AstraZeneca, Merck, Amarin, and Janssen. NJP has received research support to the institution from Amarin, Novo Nordisk, Boehringer Ingelheim, Regeneron, and AstraZeneca. Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",
year = "2019",
month = jul,
day = "1",
doi = "10.1016/j.pcad.2019.07.001",
language = "English (US)",
volume = "62",
pages = "306--314",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "4",
}